Log In
BCIQ
Print this Print this
 

CytoScan Dx Assay

Also known as: Affymetrix CytoScan Dx Assay

  Manage Alerts
Collapse Summary General Information
Company Thermo Fisher Scientific Inc.
DescriptionPostnatal assay to detect DNA copy number variants (CNVs)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationPersonal genomics testing
Indication DetailsDetect chromosomal variations that may be responsible for a child's developmental delay or intellectual disability
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1,297.0M

$1,297.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/18/2016

$1,297.0M

$1,297.0M

0

Get a free BioCentury trial today